STATUS REPORT ON MUSHROOM BASED NUTRACEUTICAL PRODUCTS IN THE MARKET
809 / 464
Authors
-
Anuradha Srivastava
ICAR-Directorate of Mushroom Research, Solan-173213 (HP)
-
Brij Lal Attri
ICAR-Directorate of Mushroom Research, Solan-173213 (HP)
-
Ved Parkash Sharma
ICAR-Directorate of Mushroom Research, Solan-173213 (HP)
Abstract
Mushrooms have been used for medicinal and food purposes since times immemorial. Many pharmaceutical substances with potent and unique properties have been isolated from mushroom and distributed worldwide.During the past decade, there has been a major expansion in the industries involved in providing these substances. These products have also been called: nutraceuticals, phytochemicals or functional foods.Many commercial nutraceutical products from medicinal mushrooms are available worldwide. These mushroom health supplements are marketed in the form of powders, capsules or tablets made of dried fruiting bodies, extracts of mycelium with substrate, biomass or extract from liquid fermentation. These products include water or alcohol extracts, concentrates, and powders in bulk or tablet form. Besides these some functional beverages from medicinal mushrooms such as mushroom tea and coffee which are rich in antioxidants and boost the immune system are also available in the market and are widely acceptable.
References
Alam N, Amin R, Khan A, Ara I, Shim M, Lee M, Lee U, Lee T. 2009. Comparative effects of oyster mushrooms on lipid profile, liver and kidney function in hypercholesterolemic rats. Mycobiology37(1): 37–42.
André A, Diamantopoulou P, Philippoussis A, Sarris D, Komaitis M, Papanikolaou S. 2010. Biotechnologicalconversions of bio-diesel derived waste glycerol into added-value compounds by higher fungi: Productionof biomass, single cell oil and oxalic acid. Ind Crop Prod 31: 407–416.
Barros L, Cruz T, Baptista P, Estevinho LM, Ferreira ICFR. 2008. Wild and commercial mushrooms as sourceof nutrients and nutraceuticals. Food ChemToxicol46: 2742–2747.
Bobek P, Ozdin L, Kuniak L.1996. Effect of oyster mushroom (Pleurotusostreatus) and its ethanolic extract in diet on absorption and turnover of cholesterol in hypercholesterolemic rat.Nahrung, 40: 222-224.
Chan GC-F, Chan WK, Sze DM-Y. 2009. The effects of beta-glucan on human immune and cancer cells. J HematolOncol2: 25.
Chang ST, Buswell JA. 1996. Mushroom nutriceuticals. World J MicrobiolBiotechnol12: 473–476.
Cheung PC. 2008. Nutritional value and health benefits of mushrooms. In: Cheung PC (ed.). Mushrooms as Functional Food. Hoboken, NJ: John Wiley & Sons, Inc. pp. 71–109.
Chihara G, Maeda Y, Hamuro J, Sasaki T, Fukuoka F. 1969.Inhibition of mouse sarcoma 180 by polysaccharides from Lentinusedodes (Berk.) Sing. Nature222: 687-688.
Chioza A and Ohga, S. 2014. Cultivated Mushrooms in Malawi: A Look at the Present Situation. Advances in Microbiology 4: 6-11.
Delena T. 1999. Edible and useful plants of Texas and South west –A practical guide university of Texas press, pp. 542.
Erjavec J, Kos J, Ravnikar M, Dreo T and Saboti J. 2012.Proteins of higher fungi from forest to application.Trends in Biotechnology30(5): 259–273.
Fasidi IA, Olorunmaiye KS.1994. Studies on the requirements for vegetative growth of Pleurotus tuber regium(Fr) Singer.Mushroom Food Chem 50: 397-401.
Gareth JEB. 1990. Edible Mushrooms in Singapore and other South East Asian countries. The Mycologist 4: 119-124.
Harsh NSK, Rai BK, Tiwari DP (1993). Use of Ganodermalucidumin folk medicine.J. Trop. Biodivers., 1: 324-326.
Hobbs C.1995. Medicinal mushrooms. an exploration of tradition, healing and culture, Botanica Press, 10226, Empire Grade, Santa Cruz, CA, 95060.
Israilides C, Kletsas D, Arapoglou D, Philippoussis A, Pratsinis H, Ebringerova A, Hribalova V, Harding SE. 2008. In vitro cytostatic and immunomodulatory properties of the medicinal mushroom Lentinulaedodes.Phytomedicine15(6–7): 512–519.
Jiskani MM. 2001.Energy potential of mushrooms. Dawn Econ. Bus. Rev., p. 4.
Kabir Y, Kimura S, Tamura T. 1988. Dietary effect of Ganodermalucidummushroom on blood pressure and lipid levels in spontaneously hypertensive rats (SHR). J NutrSciVitaminol 34: 433-438.
KalaÄP. 2013.A review of chemical composition and nutritional value of wild-growing and cultivated mushrooms.J Sci Food Agric93(2): 209–218.
Kim BK, Kim HW, Choi EC. 1993. Anti-HIV activity of Ganodermalucidum. J Bio Chem 264: 472-478.
Kino KY, Yamaoka K., Watanabe J, Kotk SK, Tsunoo H. 1989. Isolation and characterization of a new immunomodulatory protein Zhi-8 (LZ-8) from Ganodermalucidum.J Bio Chem264: 472-478.
Lindequist U, Niedermeyer TH, Julich WD. 2005. The pharmacological potential of mushrooms.EvidBasedComplementAlternat Med 2: 285–299.
Liu FO, Chang ST. 1995. Antitumor components of culture filtrates from Tricholoma sp. World J MicrobiolBiotechnol11: 486-490.
Mattila P, Salo-Vaananen P, Konko K, Aro H, Jalava T. 2002. Basic composition and amino acid contents of mushrooms cultivated in Finland.J Agric Food Chem50: 6419–6422.
Nanba H.1993. Maitake mushroom the king mushroom. Mushroom News 41: 22-25.
Oso BA. 1997. Pleurotus tuber-regiumfrom Nigeria. Mycologia69: 271-279.
Oyetayo VO, Oyetayo FL. 2005. Preliminary investigation of health promoting potentials of Lactobacillus fermentumOVL and Plerotussajorcajuadministered to rats. Pakistan J Nutr 4: 73-77.
Patel Y, Naraian Y, Singh VK. 2012. Medicinal properties of Pleurotusspecies (oyster mushroom): A review. World J Fungal Plant Biol3(1): 1–12.
Pathmashini L, Arulnandhy V and Wijeratnam RSW. 2008. Cultivation of Oyster Mushroom ( Pleurotusostreatus ) on Sawdust. Ceylon Journal of Science (Biological Sciences) 37: 177-182.
Poongkodi G K and Sakthisekaran D. 1995.Nutrient content of the mushrooms.Madras Agricultural Journal 82(9):555-556.
Rahman T, Choudhury MBK. 2012. Shiitake mushroom: A tool of medicine. Bangladesh J Med Biochem5(1): 24–32.
Ramberg JE, Nelson ED, Sinnott RA. 2010. Immunomodulatory dietary polysaccharides: A systematic review of the literature. Nutr J 9: 1–22.
Reis FS, Barros L, Martins A, Ferreira ICFR. 2012. Chemical composition and nutritional value of the most widely appreciated cultivated mushrooms: An inter-species comparative study. Food ChemToxicol50:191–197.
Ren L, Visitev AV, Grekhov AN, Tertov VV, Tutelyan VA.1989.Antiatherosclerotic properties of macrofungi.VoprosyPictaniya 1: 16-19.
Sadler M. 2003. Nutritional properties of edible fungi.Nutr Bull 28(3): 305–308.
Sagakami H, Aohi T, Simpson A, Tanuma S. 1991. Induction of immunopotentiation activity by a proteinbound polysaccharide, PSK.Anticancer Res 11: 993-1000.
Sharma TK. 2008. Vegetable caterpillar, Science Reporter. 5th May ISBN 0036-8512. National institute of science communication and information resources (NISCAIR), CSIR, pp. 33-35.
Stavinoha W, Slana J, Weintraub S, Mobley P.1991. The anti-inflammatory activity of Ganodermalucidum, Third Internationak Symposium on Ganodermalucidum, Seoul Korea.Phar Soc Korea pp. 9-21.
Tam SC, Yip KP, Fung KP and Chang ST .1986. Hypotensive and renal effects of an extract of the edible mushroom Pleurotussajor-caju. Life sciences 38(13): 1155-1161.
Tang W, Liu JW, Zhao WM, Wei DZ, Zhong JJ. 2006. Ganoderic acid T from Ganodermalucidummycelia induces mitochondria mediated apoptosis in lung cancer cells. Life Sci80(3): 205–211.
Teow SS.1997. The effective application of Ganodermanutriceuticals. In: Recent progress in Ganodermalecidumresearch (Kim BK, Moon CK, Kim TS eds.). Seoul Korea.Pharm Soc Korea pp. 21-39.
Thompson I, Oyston P, Williamson D. 2010.Potential of the β-glucans to enhance innate resistance to biological agents.Expert Rev 8(3): 339–352.
Thompson I, Oyston P, Williamson D. 2010.Potential of the β-glucans to enhance innate resistance to biological agents.Expert Rev 8(3): 339–352.
Wasser SP, Weis AL. 1999. Medicinal properties of substances occurring in higher basidiomycetes mushrooms: Current perspectives. Int J Med Mushroom 1: 31–62.
Wasser SP. 2002. Medicinal mushroom as a source of antitumor and immunomodulating polysaccharides.ApplMicrobiolBiotechnol60: 258–274.
Wasser SP. 2005. Reishi or Lingzhi (Ganodermalucidum). Encyclopedia of Dietary Supplements, Marcel Dekker, Germany, pp. 603-622.
Wasser SP. 2010a. Shiitake (Lentinusedodes). In: Coates PM, Betz GM, Blackman MR, Cragg GM, Levine M, Moss J, White JD (eds.). Encyclopedia of Dietary Supplements, 2nd edn. New York: Informa Healthcare. pp. 719–726.
Wasser SP. 2010b. Reishi or Ling Zhi. In: Coates PM, Betz GM, Blackman MR, Cragg GM, Levine M, Moss J, White JD (eds.). Encyclopedia of Dietary Supplements, 2nd edn. New York: Informa Healthcare. pp. 680–690.
Yassin M, Mahajna JA, Wasser SP. 2003. Submerged cultured mycelium extracts of higher Basidiomycetes mushrooms selectively inhibit proliferation and induce differentiation of K562 human chronic myelogenous leukemia cells. Int J Med Mushroom 5: 261–276.
Zivanovic S. 2006. Identification of opportunities for production of ingredients based on further processed fresh mushrooms, off-grade mushrooms, bi-products, and waste material. Knoxville, TN: Mushroom Council, University of Tennessee, Department of Food Science and Technology. p. 33.
Downloads
Submitted
Published
Issue
Section
License
I/We have taken permission from the copyright holder to reproduce the matter not owned by me and acknowledged the source.
I/We permit editors to publish the said paper in the journal or in any other means with editorial modification, if any.
In case of publication of the article in the journal,
I/We hereby assign copyright to the Mushroom Research Journal for its publication in any form/language including all media (print and electronic, or presently unknown), and exclusive right to use the matter for the life of the work (no time restriction on re-use of matter).Â